Weight Loss
Menopause
menu-close
WHAT WE TREAT
Weight loss
icon
Menopause
icon
ACCOUNT
Log in
icon
OVERVIEW
Weight loss overview
icon
TREATMENTS
Explore all options
Explore all options
icon
Mounjaro
Mounjaro
Lose up to 23% body weight
icon
Wegovy
Wegovy
Lose up to 21% body weight
icon
Saxenda
Saxenda
Lose up to 10% body weight
icon
Orlos
Orlos
Lose up to 8% body weight
icon
PROGRAMME
How it works
How it works
icon
Coaching
Coaching
icon
App
App
icon
ABOUT
Results
icon
Experts
icon
RESOURCES
Guides & tips
icon
ACCOUNT
Log in
icon
GET IN TOUCH
020 3912 9885
Mon-Fri 9:00-17:30
icon
OUR CLINIC
Menopause overview
icon
Pricing
icon
Specialists
icon
TREATMENT PLANS
Hormone replacement therapy
icon
Testosterone treatment
icon
Cognitive behavioural therapy
icon
Vaginal treatments
icon
BLOOD TESTS
Women's midlife (MOT) blood test
icon
Check your HRT and testosterone test
icon
Start testosterone blood test
icon
WHAT WE TREAT
Skincare
New
icon
Perimenopause
icon
Menopause
icon
ADHD and menopause
icon
Weight management
icon
LEARN
Guides
icon
Treatments
icon
ACCOUNT
Log in
icon
SUPPORT
FAQ
icon
Home/Guides & Tips/Weight loss/

Retatrutide vs Mounjaro

Retatrutide vs Mounjaro: which works better for weight loss?

Retatrutide is a weight loss medicine in development. Here’s how it compares to Mounjaro from what we know so far.

clinician image

Medically reviewed by

Dr Earim Chaudry (MBBS), Chief Medical Officer

iconPublished 12th November 2025
Research-Based Guide
Table of contents
  • At a glance: retatrutide vs Mo...
  • Is Mounjaro the same as retatr...
  • Does retatrutide actually work...
  • Retatrutide vs Mounjaro for we...
  • Side effects and tolerability
  • Availability of Mounjaro vs re...
  • Which is better: retatrutide o...

Mounjaro is the most potent weight loss injection on the market right now. But retatrutide, a new medicine that’s still being developed, might be even more effective.

So, which is better for weight loss? Read on to find out.

Key Takeaways

  • In clinical research, retatrutide shows better results than Mounjaro
  • But Mounjaro is the most potent weight loss medicine currently on the market
  • Retatrutide is expected to become available in mid-late 2026

At a glance: retatrutide vs Mounjaro comparison

Let’s take a look at how these two medicines stack up.

Features
Active ingredient
Manufacturer
Drug class
Avg. weight loss results at 48 weeks
Availability
Mounjaro
Tirzepatide
Eli Lilly
GIP and GLP-1 agonist
Around 20% (estimated from 72-week data)
Approved for weight loss. Available on NHS and via private prescription
Retatrutide
Retatrutide
Eli Lilly
GCG, GIP, and GLP-1 agonist
24.2%
Not yet approved (expected 2026)

Is Mounjaro the same as retatrutide?

Nope. Both medicines make you feel full, but they work in different ways.

Mounjaro weight loss injections mimic the behaviour of two hormones: GLP-1 and GIP. Whereas retatrutide works by bringing on the effects of three—GLP-1, GIP, and GCG. This triple action is what gives retatrutide a stronger effect.

In fact, retatrutide has driven better results in clinical trials than any other weight loss injection on the market.

Does retatrutide actually work?

From what we know so far: yes, retatrutide works very well.

Retatrutide is still being investigated in clinical trials, which means it isn’t approved yet. But the results we’ve seen are impressive.

Don't wait to hit your health goals
Retatrutide isn’t available yet, but Wegovy and Mounjaro are already helping people lose weight. Start your journey today with proven treatments and support that sticks.
icon
Science backed programme
icon
Personalised support
icon
Trusted by 100k customers across the UK

Retatrutide vs Mounjaro for weight loss: results

Okay, let’s get into it: here’s a comparison of retatrutide vs Mounjaro weight loss results.

  • The average weight loss on Mounjaro was 20.9% after 72 weeks. At the 48 week mark, mean loss was roughly 21%.
  • After 48 weeks on retatrutide, average loss was 24.2% of starting weight.

Heads up: these are results from separate clinical trials so we can’t compare them head-to-head. But they can give us an idea of how well each medicine works.

Side effects and tolerability

Again, retatrutide isn’t approved yet, so there’s no official list of side effects. Though from what’s been reported in clinical research, retatrutide side effects are similar to Mounjaro’s:

  • Nausea
  • Diarrhoea
  • Vomiting
  • Constipation

This list isn’t exhaustive. Ask your provider if you’re worried about the side effects of weight loss medicine.

Side effects support at Voy

"If you're using Voy and you experience any side effects, rest assured that our expert clinicians are just a message or phone call away. They can adjust your dose, prescribe medication to ease your symptoms, or simply offer reassurance.

Everyone responds differently to weight loss treatment and we'll help you find what feels right for you."

Phoebe Fox - Weight Loss Specialist Clinician

Availability of Mounjaro vs retatrutide

You can get Mounjaro on the NHS (though you have to meet specific criteria and there may be waitlists) or via private prescription.

Retatrutide isn’t yet available. Clinical trials are due to wrap up in May 2026, so we might see it on the market later that year.

Which is better: retatrutide or tirzepatide?

This is a tough one, because there’s no “best’ weight loss medicine—there’s only what works for you personally. And remember, retatrutide isn’t available yet.

But there are really effective weight loss medicines that are already out there, such as Mounjaro and Wegovy, which you can get through Voy’s weight loss programme. Plus, our team of clinicians and coaches will work with you to transform your lifestyle, so the weight stays off for good.

Take our quiz to see if you’re eligible.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
FAQ

Retatrutide vs Mounjaro: FAQ

Dr Earim Chaudry, MBBS
DisclaimerAt Voy, we ensure that everything you read in our blog is medically reviewed and approved. However, the information provided is not meant to replace professional medical advice, diagnosis, or treatment. It should not be relied upon for specific medical advice.
References
icon¹

Jastreboff, Ania M, et al. “Tirzepatide Once Weekly for the Treatment of Obesity.” The New England Journal of Medicine, vol. 387, no.3, 2022:205-216 https://www.nejm.org/doi/full/10.1056/NEJMoa2206038.

icon²


Jastreboff, Ania M., et al. “Triple-hormone Receptor Agonist Retatrutide for Obesity—a Phase 2 Trial,” The New England Journal of Medicine, vol. 389, no. 6, 2023:514-526 https://www.nejm.org/doi/full/10.1056/NEJMoa2301972.
“Mounjaro: Information for the Patient.” Electronic Medicines Compendium. https://www.medicines.org.uk/emc/files/pil.15481.pdf. Accessed 31 Oct. 2025.
“Obesity - Treatment,” NHS, https://www.nhs.uk/conditions/obesity/treatment/. Accessed 31 Oct. 2025.

Take the first step towards weight loss that lasts.

card-image
Weight Loss
Retatrutide and diabetes
Retatrutide is a weight loss medicine that’s still in development, but early results suggest it could help stop people from developing type 2 diabetes.
card-image
Weight Loss
How Retatrutide Works: Mechanism and Onset Explained
Retatrutide is a new experimental weight loss injection in clinical development. It mimics three natural hormones that help the body regulate hunger, manage blood sugar and use stored fat for energy.
card-image
Weight loss
Retatrutide and other weight loss injections
Retatrutide is a new weight loss injection currently being studied in clinical trials. But will you be able to take it alongside other weight loss injections?
Have a question?
phone icon
020 3912 9885Monday - Friday 9am - 5pm
support icon
help@joinvoy.comWe aim to reply in 24hrs
email icon
press@joinvoy.comPress & media inquiries
Our services are not intended for use in a medical emergency. If you need urgent medical attention, please call 111 or 999.

Programme

  • How it works
  • Treatments
  • Coaching
  • The Voy App

Voy

  • Medical experts
  • Results

Legal

  • Privacy policy
  • Terms & Conditions
  • Terms of Sale
  • Complaints

Get help

  • Help Centre (FAQ)
facebooktwitterinstagram
Copyright 2025 Voy. All rights reserved.
Pharmacies: Manual PharmacySuperintendent Pharmacist: Vinisha KandaGPhC Registration: 2203475
registered pharmacycqc ratingcpd member